Evidence map›Paper›PMID 33040466›Full record

ArticlePigment cell & melanoma research2021

Type I interferon signaling limits viral vector priming of CD8

Rebecca L Riding, Jillian M Richmond, Keitaro Fukuda, John E Harris

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pigment cell & melanoma research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Genetics of Vitiligo: A Review.Clinical, cosmetic and investigational dermatology · 2026
    Review
  4. Deciphering Depigmentation: Mouse Models for Vitiligo Research.The Journal of investigative dermatology · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Translational Research in Vitiligo.Frontiers in immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rebecca L RidingDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.ORCID 0000-0002-3698-9848
Jillian M RichmondDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.ORCID 0000-0003-1589-6770
Keitaro FukudaDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.ORCID 0000-0001-8847-0063
John E HarrisDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.
University of Massachusetts Chan Medical School · US

Funding

TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Treg Migration and Function During Autoimmunity within Peripheral TissueR01AR069114 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HARRIS, JOHN E · 2015 to 2020
$2.2M
NIAID NIH HHS T32 AI007349NIAMS NIH HHS R01 AR069114
6 · The paper itself

Abstract

Vitiligo is an autoimmune skin disease in which epidermal melanocytes are targeted for destruction by CD8

Indexed as

ImmunotherapySignal TransductionAnimalsB7-H1 AntigenCD8-Positive T-LymphocytesChemokine CXCL10Chemokine CXCL9Cross-PrimingFemaleGenetic Vectorsgp100 Melanoma AntigenHyaluronan ReceptorsInterferon Type ILigandsMaleMelanoma, ExperimentalB7-H1 AntigenCd274 protein, mouseChemokine CXCL10Chemokine CXCL9Cxcr3 protein, mousegp100 Melanoma AntigenHyaluronan ReceptorsIfnar1 protein, mouseInterferon Type ILigandsPdcd1 protein, mousePmel protein, mouseProgrammed Cell Death 1 ReceptorReceptor, Interferon alpha-betaReceptors, CXCR3autoimmunityCD8 T cellsmelanomatype I interferonvaccine immunotherapyvaccinia virusvitiligo

Identifiers

PMID33040466
PMCPMC8035367
OpenAlexW3092007848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.